The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

Author:

Louis David N1,Perry Arie2,Wesseling Pieter34ORCID,Brat Daniel J5ORCID,Cree Ian A6,Figarella-Branger Dominique7,Hawkins Cynthia8,Ng H K9,Pfister Stefan M10,Reifenberger Guido11,Soffietti Riccardo12,von Deimling Andreas1314,Ellison David W15

Affiliation:

1. Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA

2. Department of Pathology, University of California San Francisco, San Francisco, California, USA

3. Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, the Netherlands

4. Laboratory for Childhood Cancer Pathology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

5. Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

6. International Agency for Research on Cancer, World Health Organization, Lyon, France

7. Service d’Anatomie Pathologique et de Neuropathologie, APHM, CNRS, Institut de Neurophysiopathologie, Hôpital de la Timone, Aix-Marseille University, Marseille, France

8. Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

9. Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Hong Kong, China

10. Hopp Children’s Cancer Center at the NCT Heidelberg (KiTZ), Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), and Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany

11. Institute of Neuropathology, University Hospital Düsseldorf and Medical Faculty, Heinrich Heine University Düsseldorf, and German Cancer Consortium (DKTK) Partner Site Essen/Düsseldorf, Düsseldorf, Germany

12. Department of Neurology and Neuro-Oncology, University of Turin Medical School, Turin, Italy

13. Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany

14. Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany

15. Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

Abstract

Abstract The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, is the sixth version of the international standard for the classification of brain and spinal cord tumors. Building on the 2016 updated fourth edition and the work of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy, the 2021 fifth edition introduces major changes that advance the role of molecular diagnostics in CNS tumor classification. At the same time, it remains wedded to other established approaches to tumor diagnosis such as histology and immunohistochemistry. In doing so, the fifth edition establishes some different approaches to both CNS tumor nomenclature and grading and it emphasizes the importance of integrated diagnoses and layered reports. New tumor types and subtypes are introduced, some based on novel diagnostic technologies such as DNA methylome profiling. The present review summarizes the major general changes in the 2021 fifth edition classification and the specific changes in each taxonomic category. It is hoped that this summary provides an overview to facilitate more in-depth exploration of the entire fifth edition of the WHO Classification of Tumors of the Central Nervous System.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3